Comparing of Different Visual Aids Like Video,info-graphics and Pamphlets in Enhancing Community Awareness and Promoting Behavioral Change Towards the Prevention of Hypertension in Basilica of the Most Holy Trinity Onitsha Anambra State,Nigeria

January 5, 2025 updated by: Ottiwu Perpetua Chidiogor, Hiroshima University

Comparison of Different Visual Aids in Enhancing Community Awareness and Promoting Behavioral Change in the Prevention of Hypertension in Anambra State,Nigeria

The goal of this observational study is to assess different level of enhanced awareness and behavioral change of adults over the age of 35 who will be educated using video,infographic and pamphlet for the interval of one month

Study Overview

Study Type

Interventional

Enrollment (Estimated)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Japan
      • Kasumi 1-2-3 Minami-ku, Japan, Nigeria
        • Graduate School of Biomedical and Health Sciences Hiroshima University
        • Contact:
        • Contact:
          • Clementina Nwankwo, PHD
        • Contact:
          • Blessing Onyeje, PHD
        • Contact:
          • Babaita Abdulfatia, Masters

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults age over 35 years old
  • Who does not know his/her blood pressure status within the last 6 months (The person who does not know he or she has a hypertension or not.)
  • Who agree to participate

Exclusion Criteria:

  • Who cannot come to the church 4 weeks later after the intervention.
  • Known hypertensive patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: intervention group using video
Administration of video to the first intervention group
A 3 Arm randomized control trial, using video as the first Arm of intervention to assess the behaviour change of the community in hypertension prevention.
Other: intervention group using infographics
Administration of infographics to the second arm of the intervention group
A 3 Arm randomized control trial,that involves the use of infographics in Arm to assess the behaviour change of the community in hypertension prevention.
Other: control group using pamphlet
Administration of pamphlet to the control groups
A 3 Arm randomized control trial,that contains the use of pamphlet for the 3rd Arm which is the control group to assess the behaviour change of the community in hypertension prevention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavioural change in hypertension prevetion
Time Frame: One month

Behaviour changes within 1 month related to education

- Asking what kind of behaviour change occurred during 1 month Percentage caculation of participants who had behaviour change Each arm: Number of person who changed their behaviour/total number of participants in the arm

One month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the awareness level of participants from baseline after 4 week
Time Frame: 4 weeks
- Awareness check: Using the Health belief model-The researchers-developed questionnaire:How much they are motivated (pre and post comparison)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 5, 2025

Primary Completion (Estimated)

February 5, 2025

Study Completion (Estimated)

April 5, 2025

Study Registration Dates

First Submitted

December 15, 2024

First Submitted That Met QC Criteria

January 5, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 5, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MH/COMM/523/VOL.111

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To ensure confidentiality

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Intervention study for Arm one using video

Subscribe